Lin Shao-Lee: insider trades.
Lin Shao-Lee reported 7 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($1.6M), across 1 company.
- Transactions
- 7
- Purchases (P)
- 0
- Sales (S)
- 5
- Companies
- 1
- Name as filed
- Lin Shao-Lee
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Cue Biopharma, Inc. (CUE) | Director, Officer · Chief Executive Officer | 7 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-13 | Cue Biopharma, Inc. | S | 5,423 | $27.19 | 718,830 | Form 4 |
| 2026-08-13 | Cue Biopharma, Inc. | S | 10,460 | $29.48 | 705,995 | Form 4 |
| 2026-08-13 | Cue Biopharma, Inc. | S | 2,375 | $28.11 | 716,455 | Form 4 |
| 2026-08-12 | Cue Biopharma, Inc. | S | 34,225 | $26.99 | 730,028 | Form 4 |
| 2026-08-12 | Cue Biopharma, Inc. | M | 109,179 | $0 | 764,253 | Form 4 |
| 2026-08-12 | Cue Biopharma, Inc. | S | 5,775 | $27.75 | 724,253 | Form 4 |
| 2026-07-09 | Cue Biopharma, Inc. | A | 327,537 | $0 | 655,074 | Form 4 |
Questions
What stock did Lin Shao-Lee buy or sell?
Lin Shao-Lee reported 7 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($1.6M), across 1 company.
Is Lin Shao-Lee the same person as other filers with this name?
This page covers SEC CIK 1725092 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/lin-shao-lee-1725092.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.